```html

Rheumatoid Arthritis

What is Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily attacks the lining of the joints (the synovium). In people with RA, the immune system mistakenly attacks healthy tissue, causing inflammation, swelling, pain, and eventually, joint damage and loss of function. Although it most often involves the hands, wrists, and feet, RA can affect any joint in the body and may involve organs such as the lungs, heart, and eyes.

RA is different from osteoarthritis, which is a wear‑and‑tear type of arthritis. While osteoarthritis is usually localized, RA is systemic and can lead to periods of flare‑ups followed by remission. The disease affects about 1 % of the global population, most commonly women between the ages of 30 and 60, but it can develop at any age, including in children (juvenile idiopathic arthritis).

Common Causes

The exact trigger for RA remains unknown, but research points to a combination of genetic, hormonal, and environmental factors that together “turn on” the immune system. Below are the most frequently cited contributors:

• Genetic predisposition: Certain HLA‑DRB1 gene variants (the “shared epitope”) increase risk.
• Smoking: Cigarette smoke modifies lung proteins, prompting an autoimmune response.
• Hormonal influences: Higher prevalence in women suggests estrogen may play a role.
• Periodontal disease: Infections of the gums have been linked to RA onset.
• Obesity: Excess adipose tissue releases inflammatory cytokines that may trigger autoimmunity.
• Silica exposure: Occupational inhalation of silica dust (e.g., mining, construction) raises risk.
• Air pollution: Fine particulate matter may stimulate systemic inflammation.
• Infections: Certain viral (e.g., Epstein‑Barr) or bacterial infections may act as a first “hit”.
• Gut microbiome imbalance: Dysbiosis (altered gut flora) is increasingly recognized as a factor.
• Trauma or joint injury: Physical injury may expose joint antigens that trigger an immune response in predisposed individuals.

Associated Symptoms

RA is a systemic disease, so joint pain is often accompanied by a range of other manifestations:

• Morning stiffness lasting >30 minutes (often improves with movement).
• Symmetrical joint swelling—both sides of the body are typically affected.
• Fatigue, low‑grade fever, and a general feeling of being “unwell”.
• Rheumatoid nodules: firm, non‑painful lumps under the skin, especially over elbows.
• Painful, dry eyes (Sjogren’s syndrome) and dry mouth.
• Inflammation of the lungs (interstitial lung disease) or pleural effusion.
• Cardiovascular involvement – increased risk of atherosclerosis and pericarditis.
• Anemia of chronic disease.
• Joint deformities (e.g., ulnar deviation, boutonnière and swan‑neck deformities) if disease remains uncontrolled.

When to See a Doctor

Early medical evaluation dramatically improves outcomes. Contact your primary care provider or a rheumatologist if you notice any of the following:

• Persistent joint pain and swelling lasting more than a few weeks.
• Morning stiffness that does not improve after 30–60 minutes.
• Swelling in small joints of the hands, wrists, or feet that is symmetrical.
• Unexplained fatigue, low‑grade fever, or weight loss.
• Newly appearing rheumatoid nodules or skin rashes.
• Any sudden, severe joint pain that limits movement.

Because RA can cause irreversible joint damage within the first 6–12 months, prompt referral to a rheumatologist is recommended.

Diagnosis

A diagnosis of RA is based on a combination of clinical evaluation, laboratory tests, and imaging.

Clinical assessment

• Detailed medical history (symptom onset, pattern, family history).
• Physical exam focusing on joint swelling, tenderness, range of motion, and presence of nodules.

Laboratory tests

• Rheumatoid factor (RF): Positive in ~70–80 % of patients but can be seen in other diseases.
• Anti‑CCP (cyclic citrullinated peptide) antibodies: Highly specific for RA; positivity predicts more aggressive disease.
• Acute phase reactants: Elevated ESR (erythrocyte sedimentation rate) and/or CRP (C‑reactive protein) reflect inflammation.
• Complete blood count (CBC) – may show anemia.

Imaging

• X‑ray: Detects joint erosions, narrowing, and osteopenia in later stages.
• Ultrasound or MRI: More sensitive for early synovitis and erosions; useful when X‑ray is normal.

The 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria assign points for joint involvement, serology, acute‑phase reactants, and symptom duration. A total score ≥6/10 classifies a patient as having definite RA.

Treatment Options

Treatment aims to control inflammation, relieve pain, prevent joint damage, and maintain quality of life. It is usually a combination of medication, lifestyle changes, and sometimes surgery.

Medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Provide pain relief but do not slow disease progression.
• Glucocorticoids (e.g., prednisone): Rapidly reduce inflammation; used short‑term or low‑dose for flares.
• Conventional synthetic DMARDs (Disease‑Modifying Antirheumatic Drugs):
  • Methotrexate – first‑line, weekly oral or injectable.
  • Sulfasalazine, Leflunomide, Hydroxychloroquine – used as monotherapy or in combination.
• Biologic DMARDs: Target specific immune pathways.
  • TNF inhibitors – etanercept, infliximab, adalimumab.
  • IL‑6 receptor blocker – tocilizumab.
  • Co‑stimulation modulator – abatacept.
  • B‑cell depleter – rituximab.
• Targeted synthetic DMARDs: Janus kinase (JAK) inhibitors (tofacitinib, baricitinib, upadacitinib) for patients who do not respond to biologics.

Therapy is usually started early (“treat‑to‑target”) with a goal of remission or low disease activity, monitored every 1–3 months.

Physical & Occupational Therapy

• Exercise programs to preserve joint range of motion and muscle strength.
• Assistive devices (splints, ergonomic tools) to reduce joint stress.
• Education on joint protection techniques.

Home and Lifestyle Measures

• Apply heat (warm packs) for stiffness and cold packs for swelling.
• Engage in low‑impact aerobic activity (walking, swimming, cycling) 150 minutes per week.
• Balanced diet rich in omega‑3 fatty acids (fatty fish, flaxseed) and antioxidants.
• Weight management – excess weight adds stress to weight‑bearing joints.
• Quit smoking – improves treatment response and reduces progression.
• Stress‑reduction techniques (mindfulness, yoga) can lower systemic inflammation.

Surgical Options (for advanced disease)

• Synovectomy – removal of inflamed synovial tissue.
• Joint replacement (total knee, hip, or shoulder arthroplasty) when joint damage is severe.
• Tendon repair or reconstruction for deformities limiting hand function.

Prevention Tips

Because genetics cannot be altered, prevention focuses on modifiable risk factors and early detection:

• Never smoke – seek cessation programs if needed.
• Maintain a healthy BMI (Body Mass Index 18.5–24.9).
• Stay physically active to keep joints flexible and support immune balance.
• Practice good oral hygiene; treat gum disease promptly.
• Limit exposure to occupational hazards such as silica dust and chronic inhalation of pollutants.
• Consider regular health screenings if you have a first‑degree relative with RA.

Emergency Warning Signs

Key Take‑aways

• Rheumatoid arthritis is an autoimmune disease that causes symmetrical joint inflammation and can affect multiple organ systems.
• Early diagnosis and aggressive treatment with DMARDs dramatically reduce long‑term disability.
• Adopting a healthy lifestyle—quitting smoking, staying active, and maintaining a balanced diet—improves outcomes and may lower risk.
• Regular monitoring and open communication with a rheumatologist are essential for optimal disease control.

For the most current recommendations and personalized care, always discuss symptoms and treatment options with a qualified healthcare professional.

---

References:

• Mayo Clinic. Rheumatoid arthritis. https://www.mayoclinic.org
• American College of Rheumatology. 2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria. https://www.rheumatology.org
• Cleveland Clinic. Rheumatoid arthritis treatment options. https://my.clevelandclinic.org
• National Institutes of Health – National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov
• World Health Organization. Non‑communicable diseases: Rheumatic diseases. https://www.who.int

```